ALT levels at the end of follow-up in the four serologic subgroups of patients. Group A, anti-HCV and HCV-RNA negative; Group B, anti-HCV negative and HCV-RNA positive; Group C, anti-HCV and HCV-RNA positive; Group D, anti-HCV positive and HCV-RNA negative.